Open AccessDirect Observation of Retinal Microvessels in Cancer Patients After Systemic Administration of Bevacizumab and Oxaliplatin
Author(s) -
AYAKO MITSUMA,
Yasuki Ito,
TOMOYA SHIMOKATA,
Chie Tanaka,
Kay Uehara,
Goro Nakayama,
Hiroko Terasaki,
YUICHI ANDO
Publication year - 2022
Publication title -
cancer diagnosis and prognosis
Language(s) - English
Resource type - Journals
ISSN - 2732-7787
DOI - 10.21873/cdp.10113
Subject(s) - oxaliplatin , bevacizumab , medicine , chemotherapy , retinal , capecitabine , folfox , colorectal cancer , microvessel , cancer , biomarker , oncology , ophthalmology , angiogenesis , biology , biochemistry
Antiangiogenic chemotherapy is the backbone of the various anticancer therapies. To date no practical biomarker predicting their antitumor effects and toxicity has been reported. We aimed to determine the feasibility of direct retinal observation as a practical biomarker in antiangiogenic chemotherapy.